Abstract: A crosslinkable and crosslinked polymer composition containing a low density polyethylene (LDPE) homopolymer or low density polyethylene (LDPE) copolymer has excellent direct current (DC) electrical properties. The crosslinked polymer composition has an electrical conductivity of 150 fS/m or less, when measured at 70° C. and a 30 kV/mm mean electric field from a non-degassed, 1 mm thick plaque sample of the crosslinked polymer composition when measured according to a direct current (DC) conductivity method. A cable can be surrounded by at least one layer of the polymer composition.

Abstract: The invention relates to a polymer composition with improved DC electrical properties, to the use of the composition for producing a cable layer and to a cable surrounded by at least one layer comprising the polymer composition.

Abstract: Provided is a compound of the general formula (1), which is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human, as well as a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.

Abstract: A polymer composition includes a crosslinked polyolefin with improved DC electrical properties. Prior to crosslinking, the polymer composition includes a polyolefin and peroxide, in which the peroxide is in an amount of less than 35 mmol —O—O— per kilogram of the polymer composition. A cable can be surrounded by at least one layer including the polymer composition.

Abstract: An alternating current (AC) power cable includes a conductor surrounded by at least an inner semiconductive layer including a first semiconductive composition, an insulation layer including a polymer composition, an outer semiconductive layer including a second semiconductive composition, and optionally a jacketing layer including a jacketing composition, in that order. The polymer composition of the insulation layer includes an unsaturated low density polyethylene (LDPE) copolymer of ethylene with one or more polyunsaturated comonomers and a crosslinking agent. The polymer composition of the insulation layer has a dielectric loss expressed as tan ? (50 Hz) of 12.0×10?4 or less, when measured at 25 kV/mm and 130° C. according to “Test for Tan ? measurements on 10 kV cables”.

Abstract: Cooling systems for cooling various heat generating components of a vehicle are provided. A cooling system for a vehicle, according to one embodiment, includes a primary cooling assembly arranged near the front of the vehicle. The primary cooling assembly may include at least one of an air conditioning condenser configured for cooling an interior passenger space of the vehicle and a radiator for cooling a power source of the vehicle. The cooling system also includes a first electronics radiator arranged near the front of the vehicle in front of and/or adjacent to the primary cooling assembly and a second electronics radiator arranged in front of and/or adjacent to the primary cooling assembly. One or more cooling lines are operable for carrying a cooling fluid between the first and second electronics radiators and one or more electronic components disposed in the vehicle remote from the first and second electronics radiators.

Abstract: A method produces a polymer composition with improved DC electrical properties. A cable can be surrounded by at least one layer that includes the polymer composition. The polymer composition includes a polyolefin, and the polymer composition has an electric conductivity of 0.50×10?15 S/m or less, when measured according to DC conductivity method using a tape sample consisting of the polymer composition.

Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.

Abstract: Provided is a compound of the general formula (I): The compound of formula (I) is suitable for treating pulmonary fibrosis, such as Idiopathic pulmonary fibrosis in a mammal. Also provided is a method for treatment of pulmonary fibrosis, such as Idiopathic pulmonary fibrosis in a human subject having a galectin-3 level indicative of pulmonary fibrosis or exacerbation of symptoms as well as a method for making said compound.

Abstract: An embodiment of the present invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.

Abstract: An Embodiment of the invention relates to a compound of the general formula. The compound of formula is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore an embodiment of the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.

Abstract: A cable comprising one or more conductors surrounded by at least an inner semiconductive layer, an insulation layer and an outer semiconductive layer, in that order, wherein said insulation layer comprises at least 90 wt % of a polymer composition, said polymer composition comprising (I) 80.0 to 99.9 wt % of an LDPE homopolymer or copolymer; and (II) 0.1 to 20.0 wt % of: (i) an ultra-high molecular weight polyethylene having a Mw of at least 1,000,000; or (ii) a single site catalysed medium density polyethylene (MDPE) having a density of 925 to 940 kg/m3 or a single site catalysed linear low density polyethylene (LLDPE) having a density of 910 to 925 kg/m3.

Abstract: A crosslinkable and crosslinked polymer composition containing a low density polyethylene (LDPE) homopolymer or low density polyethylene (LDPE) copolymer has excellent direct current (DC) electrical properties. The crosslinked polymer composition has an electrical conductivity of 150 fS/m or less, when measured at 70° C. and a 30 kV/mm mean electric field from a non-degassed, 1 mm thick plaque sample of the crosslinked polymer composition when measured according to a direct current (DC) conductivity method. A cable can be surrounded by at least one layer of the polymer composition.

Abstract: The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.

Abstract: The present disclosure relates to a device for sonicating a biological sample. In one embodiment, a sample tube holder is pivotally suspended in a mount of a sonication device, thus allowing for a rotational degree of freedom and/or lateral movement that provides an optimized contact area between the sonotrode and the sample tube. Also disclosed is a method for sonicating a biological sample using the device described herein.

Abstract: The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-1 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-1 to a ligand in a mammal, such as a human.

Abstract: A cable comprising a conductor surrounded by at least an inner semiconductive layer, an insulation layer and an outer semiconductive layer, in that order, wherein the insulation layer is not crosslinked or is cross-linked and comprises at least 90 wt % of a polymer composition, said polymer composition comprising: (I) 95.5 to 99.9 wt % of an LDPE; and (II) 0.1 to 4.5 wt % of an HDPE having a density of at least 940 kg/m3.

Abstract: The invention relates to a polymer composition with improved DC electrical properties, to the use of the composition for producing a cable layer and to a cable surrounded by at least one layer comprising the polymer composition.

Abstract: The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.

Abstract: A power cable includes a conductor surrounded by one or more layers. At least one of the layers can include a polymer composition having an electric conductivity of 0.50×10?15 S/m or less when measured according to DC conductivity method using a tape sample. The polymer composition can include a polyolefin which is obtainable by a high pressure polymerization process. This process includes: compressing one or more monomers under pressure in a compressor, in which a compressor lubricant, such as mineral oil is used for lubrication; polymerizing a monomer optionally together with one or more comonomers in a polymerization zone; and separating the obtained polyolefin from the unreacted products and recovering the separated polyolefin in a recovery zone.